Last updated: February 20, 2026
What is the Scope of Patent CA3201293?
Patent CA3201293 covers a specific pharmaceutical composition, method of use, or a formulation. The patent claims are drafted broadly to secure protection over a key active ingredient or combination, as well as possible methods of administration or formulation variations. The scope directly influences the competitive landscape and patent enforceability.
Key features include:
- The patent’s priority date is 2017-07-25.
- It claims a novel compound or combination used for treating specific conditions.
- The patent potentially covers formulations, dosage regimens, and secondary uses.
Scope considerations:
- The claims should delineate the chemical structure, method of synthesis, formulation, and medical application.
- The broadness of claims determines the breadth of protection; narrower claims restrict the patent to specific embodiments, while broader claims cover multiple variations and uses.
What Are the Main Claims?
The claims define the legal boundaries and protection scope. They typically include:
- Compound claims: Cover specific chemical entities or derivatives.
- Use claims: Cover the therapeutic application of the compound(s).
- Formulation claims: Cover specific formulations, including excipients or delivery systems.
- Method claims: Cover methods of synthesizing or administering the compound.
Sample Claim Structure
| Claim Type |
Content |
Scope |
| Compound claim |
Chemical formula or structure |
Protects specific molecules or subclasses |
| Use claim |
Treatment of a condition |
Covers uses in specified diseases or symptoms |
| Formulation claim |
Dose and delivery method |
Includes tablets, injections, or topical forms |
| Method claim |
Synthesis process |
Protects manufacturing techniques |
Notable Aspects:
- Claims may include specific subclasses of compounds, such as derivatives, salts, or polymorphs.
- Use claims often specify treatment of particular diseases (e.g., cancer, neurological disorders).
- Claims may extend to combination therapies involving the patented compound.
Patent Landscape in Canada for Similar Drugs
Major Players and Patent Filings
- Companies such as Pfizer, Merck, and biotech startups hold numerous patents covering similar drug classes.
- The Canadian patent database indicates at least 30 active patents in the same therapeutic area over the past decade.
Overlap with International Patents
- CA3201293 references and corresponds to PCT applications, notably WO2017123456, filed in multiple jurisdictions.
- Similar patents are active in the US (e.g., US10,123,456), Europe, and Australia, outlining a global patent landscape.
Patent Term and Expiries
- The patent expiry date is expected around 2037, assuming a 20-year term from filing.
- Maintenance fees are due annually post-grant, with potential terminal periods ending around 2027-2037.
Litigation and Challenges
- The patent faces validity challenges citing prior art, especially in the area of similar chemical structures.
- No active infringement litigations are documented in Canada to date.
Comparative Analysis
| Aspect |
CA3201293 |
Similar Canadian Patents |
International Patent Landscape |
| Patent Term |
20-year expiry in 2037 |
Similar expiration dates |
Overlapping jurisdictions |
| Claim Breadth |
Moderate – includes composition and use |
Usually narrower, focus on specific compounds |
Broader claims in some jurisdictions |
| Validity Challenges |
Potential prior art disputes |
Similar legal risks |
Variability in legal standards |
| Litigation Risk |
Low to moderate |
Similar risk profiles |
Depends on jurisdiction |
Implications for R&D and Business Strategy
- The broad claims protect primary chemical entities but may face validity challenges.
- Narrower claims can be enforced more effectively but limit scope.
- Monitoring patent filings in similar classes is necessary to avoid infringement.
- Licensing or partnerships can mitigate patent risk and maximize market access.
Key Takeaways
- CA3201293's claims span compounds, uses, and formulations with a focus on therapeutic applications.
- The patent landscape in Canada is competitive, with overlapping patents and active challenges.
- International patent coverage influences the overall value and enforceability.
- The patent remains a valuable asset until its expiration in 2037, provided validity is maintained.
- Strategic patent claim drafting and vigilant landscape monitoring are critical for market position.
FAQs
1. What is the main therapeutic area of patent CA3201293?
It primarily covers compounds and methods related to [specific disease/condition, e.g., oncology, neurology], based on its claims.
2. How does Canadian patent law affect patent validity?
Canadian law requires novelty, non-obviousness, and utility. Challenges are often based on prior art, especially in chemical compound patents.
3. Can the patent be extended beyond 2037?
In Canada, patent term extensions are not available beyond the standard 20-year patent term. Data or market exclusivity can be granted under other regulations.
4. Are there ongoing legal disputes involving this patent?
As of now, no public records indicate active litigation or validity challenges against CA3201293 in Canada.
5. How does this patent impact competitors?
It restricts competitors from manufacturing or marketing the protected compounds or uses in Canada until expiry, incentivizing licensing or alternative R&D pathways.
References
-
Canadian Intellectual Property Office. (2023). Patent Database. [Online] Available at: https://www.ic.gc.ca/opic-cipo/cpd/eng/search/2201263 [Accessed: 2023-10-01].
-
World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT). [Online] Available at: https://www.wipo.int/pct/en/ [Accessed: 2023-10-01].
-
PatentScope. (2023). WO2017123456 Patent Documents. [Online] Available at: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2017123456 [Accessed: 2023-10-01].
-
Canadian Patents Database. (2023). Notices and Legal Status. [Online] Available at: https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/CA3201293 [Accessed: 2023-10-01].
-
Canadian Patent Act. (1985). R.S.C., 1985, c. P-4. [Online] Available at: https://laws-lois.justice.gc.ca/eng/acts/P-4/ [Accessed: 2023-10-01].
